# FDA Inspection 1276284 - Ajanta Pharma USA Inc - July 22, 2025

Source: https://www.globalkeysolutions.net/records/fda_inspections/ajanta-pharma-usa-inc/659b0944-41d5-43b5-a2ed-eb7d4abb5387/
Source feed: FDA_Inspections

> FDA Inspection 1276284 for Ajanta Pharma USA Inc on July 22, 2025. Classification: VAI.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1276284
- Company Name: Ajanta Pharma USA Inc
- Inspection Date: 2025-07-22
- Classification: VAI
- Project Area: Postmarketing Surveillance and Epidemiology: Human Drugs
- Product Type: Human Drugs
- Office Name: New Jersey District Office

## Related Documents

- [FDA Inspection 1276284 - 2025-07-22](https://www.globalkeysolutions.net/api/records/fda_inspections/ajanta-pharma-usa-inc/1d8acbb1-7ee0-4892-af23-e92b91353591/)
- [FDA Inspection 1049436 - 2018-04-04](https://www.globalkeysolutions.net/api/records/fda_inspections/ajanta-pharma-usa-inc/2bdaced5-f9b8-4fba-a2aa-5afbc881b127/)
- [FDA Inspection 965140 - 2016-03-17](https://www.globalkeysolutions.net/api/records/fda_inspections/ajanta-pharma-usa-inc/923413a9-339f-459b-b453-59bc8a5fed91/)

Company: https://www.globalkeysolutions.net/companies/ajanta-pharma-usa-inc/fb94ebd3-ce80-4426-8f91-9f82716e5ea6

Office: https://www.globalkeysolutions.net/offices/new-jersey-district-office/6ff5e2e9-5cff-44c7-af24-5a55329a8248